Tim is VP Clinical Development at Agomab Therapeutics, with a career that spans CRO, global pharma and innovative biotechnology companies. In his current role, he oversees the clinical strategy and execution of the company’s pipeline of novel agents targeting fibrotic diseases with a high unmet medical need.  Before joining, he spent a decade at Galapagos NV, where he held senior positions and was instrumental in shaping clinical development strategies of early development assets, next to building and maturing the PMO. Prior roles at PRA and J&J provided a solid foundation to guide complex trials and multidisciplinary teams. Tim holds a Master Degree Biomedical Sciences from the University of Antwerp, is known for his collaborative leadership style and his ability to combine rigorous scientific standards with strategic foresight.